• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • 2.0 LPBI Brochure
  • Coronavirus, SARS-CoV-2 Portal
  • Knowledge PORTALS System (KPS)
  • Journal PharmaceuticalIntelligence.com
  • 2020-21 VISTA 1.0 LPBI
  • LPBI Group’s History
  • 2020-21 VISION – 2.0 LPBI
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • LPBI Group News
  • CALENDAR
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2020 Summer Internship Portal
  • 2021 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • Contact Us
  • 1.0 LPBI Brochure

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments

Drug Delivery System – One solution for many agents for many indications

J. Biomater. Sci. Polymer Edn, Vol. 19, No. 6, pp. 755–767 (2008)  Koninklijke Brill NV, Leiden, 2008.
Also available online – http://www.brill.nl/jbs

Smart polymers for responsive drug-delivery systems

TAMAR TRAITEL, RIKI GOLDBART and JOSEPH KOST ∗
Department of Chemical Engineering, Ben-Gurion University of the Negev, P.O. Box 653,

Beer Sheva 84105, Israel

Received 29 March 2007; accepted 12 July 2007

Abstract—The rapid advancement of biomedical research has led to many creative applications for biocompatible polymers. As modern medicine discerns more mechanisms, both of physiology and of pathophysiology, the approach to healing is to mimic, or if possible, to recreate the physiology of healthy functioning. Thus, the area of smart polymers for responsive drug delivery has evolved. The developments fall under two categories: externally regulated or pulsatile systems (also known as ‘open-loop’ systems) and self-regulated systems (also known as ‘closed-loop’). The externally controlled devices apply external triggers for pulsatile delivery such as: ultrasonic, magnetic, electric, light and chemical or biochemical agents. The self-regulated systems, on the other hand, are defined as systems where the controlled variable is detected, and as a result, the system output is adjusted accordingly. The release rate is controlled by feedback information, without any external intervention. The self-regulated systems utilize several approaches for the rate control mechanisms such as thermal, pH-sensitive polymers, enzyme–substrate reactions, pH-sensitive drug solubility, competitive binding, antibody interactions and metal-concentration-dependent hydrolysis.

Key words: Responsive drug-delivery system; intelligent drug-delivery systems; smart polymers; externally regulated; pulsatile; self-regulation; ‘open-loop’; ‘closed-loop’.

INTRODUCTION

The rapid advancement of biomedical research has led to many creative applications for biocompatible polymers. As modern medicine discerns more mechanisms, both of physiology and of pathophysiology, the approach to healing is to mimic, or if possible, to recreate the physiology of healthy functioning. Smart polymeric drug-delivery systems have the ability to respond to environmental changes and consequently, alter their properties reversibly enabling an efficient and safe drug delivery.

The developments fall under two categories: externally regulated or pulsatile systems (also known as ‘open-loop’ systems) and self-regulated systems (also

∗To whom correspondence should be addressed. E-mail: kost@bgu.ac.il

Review

756 T. Traitel et al.
known as ‘closed-loop’). The following chapter outlines the fundamentals of this

research area.

DEVELOPMENT OF CONTROLLED DRUG DELIVERY SYSTEMS

Control of drug concentration levels over time

While newer and more powerful drugs continue to be developed, increasing attention is being given to the methods of administering these active substances. In conventional drug delivery, the drug concentration in the blood rises when the drug is taken, then peaks and declines. Maintaining drug in the desired therapeutic range with just a single dose, or targeting the drug to a specific area (lowering the systemic drug levels), are goals that have been successfully attained with commercially available controlled release devices [1, 2]. However, there are many clinical situations where the approach of a constant drug delivery rate is insufficient, such as the delivery of insulin for patients with diabetes mellitus, anti-arrhythmics for patients with heart rhythm disorders, gastric acid inhibitors for ulcer control and nitrates for patients with angina pectoris. The onset of infection of medical device or biomaterial surfaces is an additional clinical situation where responsive delivery system of anti-inflammatory drugs can be useful. Furthermore, studies in the field of chronopharmacology indicate that the onset of certain diseases exhibit strong circadian temporal dependence. Therefore, time-dependent release of drugs, such as β-blockers, birth control, general hormone replacement, immunization and cancer chemotherapy, is required.

Treatment of all these clinical scenarios could be optimized through the use of responsive (‘smart’) delivery systems [3 – 9], which are, in essence, man-made imitations of healthy functioning.

Smart Polymers – Kost

  • Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,063 other followers

  • Recent Posts

    • National Resilience, Inc. is a first-of-its-kind manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption – the Acquisition of Two Premier Biologics Manufacturing Facilities: Boston and in Ontario, Canada March 4, 2021
    • 19 of the 49 New Therapeutic Molecular Entities FDA approved in 2020 — as well as a new Cell-based therapy — are Personalized Medicines March 2, 2021
    • Happy 80th Birthday: Radioiodine (RAI) Theranostics: Collaboration between Physics and Medicine, the Utilization of Radionuclides to Diagnose and Treat: Radiation Dosimetry by Discoverer Dr. Saul Hertz, the early history of RAI in diagnosing and treating Thyroid diseases and Theranostics March 2, 2021
    • 2.0 LPBI is a Very Unique Organization  March 2, 2021
    • FDA emergency use authorization would bring the public a third vaccine for the novel coronavirus – J&J single vaccine – Authorized on 2/28/2021 March 1, 2021
    • Medical Device Representatives coach Surgeons in the Operating Rooms March 1, 2021
    • 2021 Virtual World Medical Innovation Forum, Mass General Brigham, Gene and Cell Therapy, VIRTUAL May 19–21, 2021 February 26, 2021
    • Inhibitory CD161 receptor recognized as a potential immunotherapy target in glioma-infiltrating T cells by single-cell analysis February 20, 2021
    • First single-course ‘curative’ CRISPR Shot by Intellia rivals Alnylam, Ionis and Pfizer February 19, 2021
    • Contribution of Nervous System Functional Deterioration to late-life Mortality: The Role Neurofilament light chain (NfL) a Blood Biomarker for the Progression of Neurological Diseases and its Correlation to Age and Life Expectancy February 19, 2021
  • Archives

  • Categories

  • Meta

    • Register
    • Log in
    • Entries feed
    • Comments feed
    • WordPress.com
    • 2012pharmaceutical
    • Amandeep Kaur
    • Aashir Awan, Phd
    • Adina Hazan
    • Alan F. Kaul, PharmD., MS, MBA, FCCP
    • alexcrystal6
    • anamikasarkar
    • apreconasia
    • aviralvatsa
    • David Orchard-Webb, PhD
    • danutdaagmailcom
    • Demet Sag, Ph.D., CRA, GCP
    • Daniel Menzin
    • Dror Nir
    • dsmolyar
    • evelinacohn
    • Gail S Thornton
    • Irina Robu
    • jayzmit48
    • jdpmd
    • jshertok
    • kellyperlman
    • Ed Kislauskis
    • larryhbern
    • Madison Davis
    • marzankhan
    • megbaker58
    • ofermar2020
    • Dr. Pati
    • pkandala
    • Rosalind Codrington, PhD
    • ritusaxena
    • Rick Mandahl
    • sjwilliamspa
    • stuartlpbi
    • Dr. Sudipta Saha
    • tildabarliya
    • zraviv06
    • zs22

Blog at WordPress.com.

WPThemes.